T cell receptor excision circles and HIV-1 2-LTR episomal DNA to predict AIDS in patients not receiving effective therapy

被引:14
|
作者
Goedert, JJ [1 ]
O'Brien, TR
Hatzakis, A
Kostrikis, LG
机构
[1] NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA
[2] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA
[3] Univ Athens, Sch Med, Dept Hyg & Epidemiol, Natl Retrovirus Reference Ctr, GR-11527 Athens, Greece
关键词
AIDS incidence; prospective cohort study; hemophilia; T-cell production; HIV-1; replication;
D O I
10.1097/00002030-200111230-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To determine whether improved prediction of AIDS-free survival following HIV-1 seroconversion is achieved by measuring HIV-1 2-LTR episomal DNA (2-LTR) circles and T cell receptor rearrangement excision circles (TREC), reflecting HIV replication and lymphocyte emigration from the thymus, respectively. Design: Subanalysis of a cohort of 154 patients with hemophilia who became HIV positive between 1978 and 1985 and were followed prospectively. Methods: Relative hazards (RH) of AIDS, in the absence of highly effective anti-HIV therapy, were estimated for age, HIV-1 viral load, CD4 lymphocyte count and levels of HIV-1 2-LTR circles and TREC [per 10(6) peripheral blood mononuclear cells (PBMC)] Results: TREC correlated significantly with CD4 cell counts (r = 0.30) and age (r = -0.60). 2-LTR circles correlated significantly with HIV-1 viral load (r = 0.35). If viral load, CD4 lymphocytes and age were included in a proportional hazards model, the risk of AIDS during a median of 11.6 years of follow-up was increased significantly with fewer TREC (adjusted RH, 2.0 per log(10) copies/10(6) PBMC) and more 2-LTR circles (RH, 1.7 per log(10) copies/10(6) PBMC). AIDS prediction with TREC and 2-LTR circles held for most subgroups defined by median viral load, CD4 lymphocytes and age. Conclusions: PBMC that have high levels of HIV-1 replication and low levels of recent thymic emigrants are associated with a substantially increased risk of AIDS. It is not known if measurement of either TREC or 2-LTR circles will complement HIV-11 viral load as an estimation of the risk of AIDS for patients who are receiving highly effective anti-HIV therapy. (C) 2001 Lippincott Williams Wilkins.
引用
收藏
页码:2245 / 2250
页数:6
相关论文
共 50 条
  • [41] T-cell and B-cell perturbations are similar in ART-naive HIV-1 and HIV-1/2 dually infected patients
    Honge, Bo L.
    Petersen, Mikkel S.
    Jespersen, Sanne
    Medina, Candida
    Te, David D. S.
    Kjerulff, Bertram
    Jensen, Mads M.
    Steiniche, Ditte
    Esbjornsson, Joakim
    Laursen, Alex L.
    Wejse, Christian
    Krarup, Henrik
    Moller, Bjarne K.
    Erikstrup, Christian
    Rodrigues, Amabelia
    da Silva, Zacarias
    Oliviera-Souto, Ines
    Ostergaard, Lars
    Laursen, Alex Lund
    Aaby, Peter
    Fomsgaard, Anders
    AIDS, 2019, 33 (07) : 1143 - 1153
  • [42] Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy
    Galli, M
    Balotta, C
    Meroni, L
    Colombo, MC
    Papagno, L
    Bagnarelli, P
    Testa, L
    Varchetta, S
    Colombo, L
    Moroni, M
    Monforte, AD
    Clerici, M
    Clementi, M
    AIDS, 1998, 12 (18) : 2500 - 2502
  • [43] Peripheral immune phenotypes and T cell receptor repertoire in pneumocystis pneumonia in HIV-1 infected patients
    Qiao, Luxin
    Cui, Xiao
    Jia, Lin
    Gao, Yuxue
    Wang, Wenjing
    Wei, Feili
    Zhang, Zhili
    Chen, Dexi
    Ma, Yingmin
    Zhang, Yulin
    CLINICAL IMMUNOLOGY, 2022, 237
  • [44] GAMMA-DELTA T-CELL RECEPTOR SUBSETS IN THE LUNG OF PATIENTS WITH HIV-1 INFECTION
    AGOSTINI, C
    ZAMBELLO, R
    TRENTIN, L
    CERUTTI, A
    BULIAN, P
    CRIVELLARO, C
    CIPRIANI, A
    SEMENZATO, G
    CELLULAR IMMUNOLOGY, 1994, 153 (01) : 194 - 205
  • [45] Hepatitis C Therapy With Interferon-α and Ribavirin Reduces CD4 T-Cell-Associated HIV-1 DNA in HIV-1/Hepatitis C Virus-Coinfected Patients
    Sun, Hong
    Buzon, Maria J.
    Shaw, Amy
    Berg, Randi Karteebahn
    Yu, Xu G.
    Ferrando-Martinez, Sara
    Leal, Manuel
    Ruiz-Mateos, Ezequiel
    Lichterfeld, Mathias
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (09): : 1315 - 1320
  • [46] Delayed HIV-1 infection of CD4+ T lymphocytes from therapy-naive patients demonstrated by quantification of HIV-1 DNA copy numbers
    Wada, K
    Nagai, H
    Hagiwara, T
    Ibe, S
    Utsumi, M
    Kaneda, T
    MICROBIOLOGY AND IMMUNOLOGY, 2004, 48 (10) : 767 - 772
  • [47] Serum HIV-1 RNA load to predict CD4(+) T-cell depletion in asymptomatic patients
    Lafeuillade, A
    Poggi, C
    Pellegrino, P
    Profizi, N
    INFECTION, 1996, 24 (03) : 245 - 247
  • [48] In Vitro HIV-1 LTR Integration into T-Cell Activation Gene CD27 Segment and the Decoy Effect of Modified-Sequence DNA
    Ohmori, Rei
    Tsuruyama, Tatsuaki
    PLOS ONE, 2012, 7 (11):
  • [49] T-CELL RECEPTOR V-BETA-12 GENE USAGE IN HIV-1 SERONEGATIVE AND SEROPOSITIVE PATIENTS SUPPORTS THE HYPOTHESIS THAT HIV-1 ENCODES A SUPERANTIGEN
    SHANKAR, P
    LIEBERMAN, J
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 70 - 70
  • [50] Dynamics of spontaneous HIV-1 specific and non-specific B-cell responses in patients receiving antiretroviral therapy
    Fournier, AM
    Baillat, V
    Alix-Panabieres, C
    Fondere, JM
    Merle, C
    Segondy, M
    Huguet, MF
    Reynes, J
    Vendrell, JP
    AIDS, 2002, 16 (13) : 1755 - 1760